WAS
VRTX icon

WESPAC Advisors SoCal’s Vertex Pharmaceuticals VRTX Stock Holding History

WESPAC Advisors SoCal’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,975
Closed -$1.61M – 90
2021
Q2 		$1.61M Buy
7,975
+4,685
+142% +$980K 0.53% 41
2021
Q1 		$707K Buy
3,290
+300
+10% +$65.9K 0.28% 53
2020
Q4 		$707K Buy
+2,990
New +$686K 0.28% 49
2016
Q2 		– Sell
-50
Closed -$3.97K – 313
2016
Q1 		$3.97K Hold
50
– – ﹤0.01% 246
2015
Q4 		$6K Buy
+50
New +$6.04K ﹤0.01% 212

Other funds holding VRTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return